{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:30:53Z","timestamp":1793853053548,"version":"4.6.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03400-y","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:09:41Z","timestamp":1777910981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cyclodextrins: Synthesis, Pharmaceutical Applications, Drug Delivery Systems and Safety Perspectives"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3025-7336","authenticated-orcid":false,"given":"Aman","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-5009","authenticated-orcid":false,"given":"Ravi Raj","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-2241","authenticated-orcid":false,"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-3856","authenticated-orcid":false,"given":"Atul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-748X","authenticated-orcid":false,"given":"Nitin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-9922","authenticated-orcid":false,"given":"Umesh Kumar","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":false,"given":"Balak Das","family":"Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"2","key":"3400_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/17425247.2.1.335","volume":"2","author":"T Loftsson","year":"2005","unstructured":"Loftsson T, Jarho P, M\u00e1sson M, J\u00e4rvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005;2(2):335\u201351.","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"3400_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/biom11030401","volume":"11","author":"S W\u00fcpper","year":"2021","unstructured":"W\u00fcpper S, L\u00fcersen K, Rimbach G. Cyclodextrins, natural compounds, and plant bioactives\u2014a nutritional perspective. Biomolecules. 2021;11(3):401.","journal-title":"Biomolecules"},{"issue":"3","key":"3400_CR3","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s10311-020-01156-w","volume":"19","author":"N Morin-Crini","year":"2021","unstructured":"Morin-Crini N, Fourmentin S, Fenyvesi \u00c9, Lichtfouse E, Torri G, Fourmentin M, et al. 130 years of cyclodextrin discovery for health, food, agriculture, and the industry: a review. Environ Chem Lett. 2021;19(3):2581\u2013617.","journal-title":"Environ Chem Lett"},{"key":"3400_CR4","doi-asserted-by":"crossref","unstructured":"Kfoury M, Fourmentin S. State of the art in cyclodextrin solubility enhancement. Are green solvents the solution?. J Mol Liq. 2024;410:125599.","DOI":"10.1016\/j.molliq.2024.125599"},{"issue":"4","key":"3400_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1381612825666190306163602","volume":"25","author":"SY Raut","year":"2019","unstructured":"Raut SY, Manne ASN, Kalthur G, Jain S, Mutalik S. Cyclodextrins as carriers in targeted delivery of therapeutic agents: focused review on traditional and inimitable applications. Curr Pharm Des. 2019;25(4):444\u201354.","journal-title":"Curr Pharm Des"},{"issue":"15","key":"3400_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119181","volume":"579","author":"P Mura","year":"2020","unstructured":"Mura P. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: a review. Int J Pharm. 2020;579(15):119181.","journal-title":"Int J Pharm"},{"issue":"7","key":"3400_CR7","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1021\/cr050253g","volume":"107","author":"R Villalonga","year":"2007","unstructured":"Villalonga R, Cao R, Fragoso A. Supramolecular chemistry of cyclodextrins in enzyme technology. Chem Rev. 2007;107(7):3088\u2013116.","journal-title":"Chem Rev"},{"issue":"10","key":"3400_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nano8100847","volume":"8","author":"I Yakavets","year":"2018","unstructured":"Yakavets I, Lassalle H-P, Scheglmann D, Wiehe A, Zorin V, Bezdetnaya L. Temoporfin-in-cyclodextrin-in-liposome\u2014a new approach for anticancer drug delivery: the optimization of composition. Nanomaterials. 2018;8(10):847.","journal-title":"Nanomaterials"},{"issue":"21","key":"3400_CR9","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.1021\/cr500081p","volume":"114","author":"G Crini","year":"2014","unstructured":"Crini G. Review: a history of cyclodextrins. Chem Rev. 2014;114(21):10940\u201375.","journal-title":"Chem Rev"},{"key":"3400_CR10","doi-asserted-by":"crossref","unstructured":"van der Veen BA, Uitdehaag JC, Dijkstra BW, Dijkhuizen L. Engineering of cyclodextrin glycosyltransferase reaction and product specificity. Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology. 2000;1543(2):336\u201360.","DOI":"10.1016\/S0167-4838(00)00233-8"},{"issue":"1","key":"3400_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0006-291X(61)90071-7","volume":"5","author":"AO Pulley","year":"1961","unstructured":"Pulley AO, French D. Studies on the Schardinger dextrins. XI. The isolation of new Schardinger dextrins. Biochem Biophys Res Commun. 1961;5(1):11\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3400_CR12","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s10311-021-01244-5","volume":"19","author":"M Petitjean","year":"2021","unstructured":"Furue M, Harada A, Nozakura SI. Preparation of cyclodextrin\u2010containing polymers and their catalysis in ester\u2010hydrolysis. J Polym Sci, Polym Lett Ed. 1975 Jun;13(6):357-60.","journal-title":"Environ Chem Lett"},{"key":"3400_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2044.2008.05868.x","volume":"64","author":"LH Booij","year":"2009","unstructured":"Booij LH. Cyclodextrins and the emergence of sugammadex. Anaesthesia. 2009;64:31\u20137.","journal-title":"Anaesthesia"},{"key":"3400_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-49308-0","volume-title":"The history of cyclodextrins","author":"N Morin-Crini","year":"2020","unstructured":"Morin-Crini N, Fourmentin S, Fenyvesi \u00c9, Lichtfouse E, Torri G, Fourmentin M, et al. History of cyclodextrins. In: The history of cyclodextrins. 2020. p. 1\u201393."},{"issue":"1","key":"3400_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112758","volume":"218","author":"AC Paiva-Santos","year":"2022","unstructured":"Paiva-Santos AC, Ferreira L, Peixoto D, Silva F, Soares MJ, Zeinali M, et al. Cyclodextrins as an encapsulation molecular strategy for volatile organic compounds\u2014pharmaceutical applications. Colloids Surf B Biointerfaces. 2022;218(1):112758.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"19","key":"3400_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29194782","volume":"29","author":"A Anitha","year":"2024","unstructured":"Anitha A, Rajamohan R, Murugan M, Seo JH. Inclusion complexation of Remdesivir with cyclodextrins: a comprehensive review on combating coronavirus resistance\u2014current state and future perspectives. Molecules. 2024;29(19):4782.","journal-title":"Molecules"},{"issue":"1","key":"3400_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1039\/D2MA00797E","volume":"4","author":"A Adhikari","year":"2023","unstructured":"Adhikari A, Mandal D, Rana D, Nath J, Bose A, Orasugh JT, et al. COVID-19 mitigation: nanotechnological intervention, perspective, and future scope. Materials Advances. 2023;4(1):52\u201378.","journal-title":"Materials Advances"},{"issue":"11","key":"3400_CR18","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/polym13111759","volume":"13","author":"J \u0141agiewka","year":"2021","unstructured":"\u0141agiewka J, Girek T, Ciesielski W. Cyclodextrins-peptides\/proteins conjugates: synthesis, properties and applications. Polymers. 2021;13(11):1759.","journal-title":"Polymers"},{"issue":"5","key":"3400_CR19","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/ijms10052031","volume":"10","author":"L Zhang","year":"2009","unstructured":"Zhang L, Zhu W, Song L, Wang Y, Jiang H, Xian S, et al. Effects of hydroxylpropyl-\u03b2-cyclodextrin on in vitro insulin stability. Int J Mol Sci. 2009;10(5):2031\u201340.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3400_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.121985","volume":"333","author":"J Huang","year":"2024","unstructured":"Huang J, Wang X, Huang T, Yang Y, Tu J, Zou J, et al. Application of sodium sulfobutylether-\u03b2-cyclodextrin based on encapsulation. Carbohydr Polym. 2024;333(1):121985.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"3400_CR21","first-page":"139","volume":"55","author":"S Shimpi","year":"2005","unstructured":"Shimpi S, Chauhan B, Shimpi P. Cyclodextrins: application in different routes of drug administration. Acta Pharm. 2005;55(2):139\u201356.","journal-title":"Acta Pharm"},{"issue":"9","key":"3400_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.carres.2007.02.033","volume":"342","author":"AD French","year":"2007","unstructured":"French AD, Johnson GP. Linkage and pyranosyl ring twisting in cyclodextrins. Carbohydr Res. 2007;342(9):1223\u201337.","journal-title":"Carbohydr Res"},{"issue":"8","key":"3400_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8080314","volume":"8","author":"H Wang","year":"2019","unstructured":"Wang H, Wang S, Zhu H, Wang S, Xing J. Inclusion complexes of lycopene and \u03b2-cyclodextrin: preparation, characterization, stability and antioxidant activity. Antioxidants. 2019;8(8):314.","journal-title":"Antioxidants"},{"key":"3400_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/bk-2019-1309.ch009","volume-title":"Targeted nanosystems for therapeutic applications: New concepts, dynamic properties, efficiency, and toxicity","author":"RK Sanku","year":"2019","unstructured":"Sanku RK, Karakus OO, Ilies M, Ilies MA. Inclusion complexes in drug delivery and drug targeting: formation, characterization, and biological applications. In: Targeted nanosystems for therapeutic applications: New concepts, dynamic properties, efficiency, and toxicity. ACS Publications; 2019. p. 187\u2013221."},{"issue":"1","key":"3400_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15685551.2023.2205741","volume":"26","author":"YF Li","year":"2023","unstructured":"Li YF, Tian ZX, Shi B, He YB, Long MX. Synthesis and structural characterization of \u03b2 -cyclodextrin butenate. Des Monomers Polym. 2023;26(1):132\u20139.","journal-title":"Des Monomers Polym"},{"issue":"14","key":"3400_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/ac00038a022","volume":"64","author":"AK Chatjigakis","year":"1992","unstructured":"Chatjigakis AK, Donze C, Coleman AW, Cardot P. Solubility behavior of. beta.-cyclodextrin in water\/cosolvent mixtures. Anal Chem. 1992;64(14):1632\u20134.","journal-title":"Anal Chem"},{"issue":"9","key":"3400_CR27","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/j.xphs.2016.01.019","volume":"105","author":"A Ryzhakov","year":"2016","unstructured":"Ryzhakov A, Do Thi T, Stappaerts J, Bertoletti L, Kimpe K, S\u00e1 Couto AR, et al. Self-Assembly of Cyclodextrins and Their Complexes in Aqueous Solutions. J Pharm Sci. 2016;105(9):2556\u201369.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3400_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0192623307310945","volume":"36","author":"VJ Stella","year":"2008","unstructured":"Stella VJ, He Q. Cyclodextrins. Toxicol Pathol. 2008;36(1):30\u201342.","journal-title":"Toxicol Pathol"},{"issue":"3","key":"3400_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10847-016-0630-3","volume":"85","author":"E Cho","year":"2016","unstructured":"Cho E, Jeong D, Choi Y, Jung S. Properties and current applications of bacterial cyclic \u03b2-glucans and their derivatives. J Incl Phenom Macrocycl Chem. 2016;85(3):175\u201385.","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"25","key":"3400_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121654","volume":"618","author":"P Jansook","year":"2022","unstructured":"Jansook P, Loftsson T. Self-assembled \u03b3-cyclodextrin as nanocarriers for enhanced ocular drug bioavailability. Int J Pharm. 2022;618(25):121654.","journal-title":"Int J Pharm"},{"issue":"1","key":"3400_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijpharm.2016.10.062","volume":"516","author":"P Saokham","year":"2017","unstructured":"Saokham P, Loftsson T. \u03b3-Cyclodextrin. Int J Pharm. 2017;516(1):278\u201392.","journal-title":"Int J Pharm"},{"key":"3400_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.yrtph.2004.05.008","volume":"39","author":"IC Munro","year":"2004","unstructured":"Munro IC, Newberne PM, Young VR, B\u00e4r A. Safety assessment of \u03b3-cyclodextrin. Regul Toxicol Pharmacol. 2004;39:3\u201313.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"3400_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051228","volume":"23","author":"L Szente","year":"2018","unstructured":"Szente L, Singhal A, Domokos A, Song B. Cyclodextrins: assessing the impact of cavity size, occupancy, and substitutions on cytotoxicity and cholesterol homeostasis. Molecules. 2018;23(5):1228.","journal-title":"Molecules"},{"key":"3400_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/B978-0-12-804307-3.00017-X","volume":"1","author":"PK Zarzycki","year":"2016","unstructured":"Zarzycki PK, G\u0142\u00f3d BK. Cyclodextrins-based nanocomplexes for encapsulation of bioactive compounds in food, cosmetics, and pharmaceutical products: Principles of supramolecular complexes formation, their influence on the antioxidative properties of target chemicals, and recent advances in selected industrial applications. Encapsulations. 2016;1:717\u201367.","journal-title":"Encapsulations"},{"issue":"4","key":"3400_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/2211550103666141027220452","volume":"3","author":"A Avci","year":"2014","unstructured":"Avci A, N Nichols N, C Saha B, E Frazer S, A Cotta M, Donmez S. A thermostable cyclodextrin glycosyltransferase from Thermoanaerobacter sp. 5K. Current Biotechnology. 2014;3(4):305\u201312.","journal-title":"Current Biotechnology"},{"issue":"6","key":"3400_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00253-002-1057-x","volume":"59","author":"A Biwer","year":"2002","unstructured":"Biwer A, Antranikian G, Heinzle E. Enzymatic production of cyclodextrins. Appl Microbiol Biotechnol. 2002;59(6):609\u201317.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3400_CR37","first-page":"1","volume":"17","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Zhu T, Gu Z, Li Z, Ban X, Hong Y, et al. Cyclodextrin glycosyltransferases for food innovation: from molecular mechanism to industrial application. Crit Rev Food Sci Nutr. 2025;17:1\u20137.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3400_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06305","author":"CH Lim","year":"2021","unstructured":"Lim CH, Rasti B, Sulistyo J, Hamid MA. Comprehensive study on transglycosylation of CGTase from various sources. Heliyon. 2021. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06305.","journal-title":"Heliyon"},{"issue":"19","key":"3400_CR39","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1007\/s00253-023-12708-9","volume":"107","author":"DS Pardhi","year":"2023","unstructured":"Pardhi DS, Rabadiya KJ, Panchal RR, Raval VH, Joshi RG, Rajput KN. Cyclodextrin glucanotransferase: fundamentals and biotechnological implications. Appl Microbiol Biotechnol. 2023;107(19):5899\u2013907.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"3400_CR40","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1046\/j.1432-1327.2000.01031.x","volume":"267","author":"BA van der Veen","year":"2000","unstructured":"van der Veen BA, van Alebeek GJW, Uitdehaag JC, Dijkstra BW, Dijkhuizen L. The three transglycosylation reactions catalyzed by cyclodextrin glycosyltransferase from Bacillus circulans (strain 251) proceed via different kinetic mechanisms. Eur J Biochem. 2000;267(3):658\u201365.","journal-title":"Eur J Biochem"},{"issue":"5","key":"3400_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00253-004-1781-5","volume":"66","author":"Q Qi","year":"2005","unstructured":"Qi Q, Zimmermann W. Cyclodextrin glucanotransferase: from gene to applications. Appl Microbiol Biotechnol. 2005;66(5):475\u201385.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3400_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0141-0229(01)00461-6","volume":"30","author":"RF Martins","year":"2002","unstructured":"Martins RF, Hatti-Kaul R. A new cyclodextrin glycosyltransferase from an alkaliphilic Bacillus agaradhaerens isolate: purification and characterisation. Enzyme Microb Technol. 2002;30(1):116\u201324.","journal-title":"Enzyme Microb Technol"},{"issue":"9-10","key":"3400_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0141-0229(01)00347-7","volume":"28","author":"B Gawande","year":"2001","unstructured":"Gawande B, Patkar A. Purification and properties of a novel raw starch degrading-cyclodextrin glycosyltransferase from Klebsiella pneumoniae AS-22. Enzyme Microb Technol. 2001;28(9\u201310):735\u201343.","journal-title":"Enzyme Microb Technol"},{"issue":"9","key":"3400_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","volume":"39","author":"EM Del Valle","year":"2004","unstructured":"Del Valle EM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033\u201346.","journal-title":"Process Biochem"},{"issue":"8","key":"3400_CR45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0141-0229(97)00263-9","volume":"22","author":"A Tonkova","year":"1998","unstructured":"Tonkova A. Bacterial cyclodextrin glucanotransferase. Enzyme Microb Technol. 1998;22(8):678\u201386.","journal-title":"Enzyme Microb Technol"},{"key":"3400_CR46","doi-asserted-by":"crossref","unstructured":"Kobayashi S. Cyclodextrin producing enzyme (CGTase). InProgress in Biotechnology 1996 Jan 1 (Vol. 12, pp. 23\u201341). Elsevier.","DOI":"10.1016\/S0921-0423(96)80360-1"},{"issue":"2","key":"3400_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10822-025-00694-1","volume":"39","author":"E Napi\u00f3rkowska","year":"2025","unstructured":"Napi\u00f3rkowska E, Szeleszczuk \u0141. Conformational landscape of \u03b2-cyclodextrin: a computational resource for host\u2013guest modeling in supramolecular systems. J Comput Aided Mol Des. 2025;39(2):1\u201315.","journal-title":"J Comput Aided Mol Des"},{"issue":"8","key":"3400_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/chir.22712","volume":"29","author":"A Maheshwari","year":"2017","unstructured":"Maheshwari A, Saraswat H, Upadhyay SK. Structural insights into the inclusion complexes between clomiphene citrate and \u03b2-cyclodextrin: the mechanism of preferential isomeric selection. Chirality. 2017;29(8):451\u20137.","journal-title":"Chirality"},{"issue":"5","key":"3400_CR49","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1021\/cr970019t","volume":"98","author":"H-J Schneider","year":"1998","unstructured":"Schneider H-J, Hacket F, R\u00fcdiger V, Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem Rev. 1998;98(5):1755\u201386.","journal-title":"Chem Rev"},{"issue":"17","key":"3400_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179422","volume":"22","author":"AH Mazurek","year":"2021","unstructured":"Mazurek AH, Szeleszczuk \u0141, Gubica T. Application of molecular dynamics simulations in the analysis of cyclodextrin complexes. Int J Mol Sci. 2021;22(17):9422.","journal-title":"Int J Mol Sci"},{"issue":"27","key":"3400_CR51","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1021\/jp901581e","volume":"113","author":"G Raffaini","year":"2009","unstructured":"Raffaini G, Ganazzoli F, Malpezzi L, Fuganti C, Fronza G, Panzeri W, et al. Validating a strategy for molecular dynamics simulations of cyclodextrin inclusion complexes through single-crystal X-ray and NMR experimental data: a case study. J Phys Chem B. 2009;113(27):9110\u201322.","journal-title":"J Phys Chem B"},{"issue":"30","key":"3400_CR52","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.1039\/D4SC01061B","volume":"15","author":"P Su","year":"2024","unstructured":"Su P, Zhu X, Wilson SM, Feng Y, Samayoa-Oviedo HY, Sonnendecker C, et al. The effect of host size on binding in host\u2013guest complexes of cyclodextrins and polyoxometalates. Chem Sci. 2024;15(30):11825\u201336.","journal-title":"Chem Sci"},{"issue":"13","key":"3400_CR53","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/marc.201400080","volume":"35","author":"S Tan","year":"2014","unstructured":"Tan S, Ladewig K, Fu Q, Blencowe A, Qiao GG. Cyclodextrin-based supramolecular assemblies and hydrogels: recent advances and future perspectives. Macromol Rapid Commun. 2014;35(13):1166\u201384.","journal-title":"Macromol Rapid Commun"},{"issue":"14","key":"3400_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30143044","volume":"30","author":"I Spiridon","year":"2025","unstructured":"Spiridon I, Anghel N. Cyclodextrins as multifunctional platforms in drug delivery and beyond: structural features, functional applications, and future trends. Molecules. 2025;30(14):3044.","journal-title":"Molecules"},{"key":"3400_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28196964","author":"L Adamkiewicz","year":"2023","unstructured":"Adamkiewicz L, Szeleszczuk \u0141. Review of applications of cyclodextrins as taste-masking excipients for pharmaceutical purposes. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28196964.","journal-title":"Molecules"},{"issue":"10","key":"3400_CR56","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1002\/jps.22153","volume":"99","author":"FM Mady","year":"2010","unstructured":"Mady FM, Abou-Taleb AE, Khaled KA, Yamasaki K, Iohara D, Ishiguro T, et al. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug\/SBE-beta-CyD\/povidone K30 complexation approach. J Pharm Sci. 2010;99(10):4285\u201394.","journal-title":"J Pharm Sci"},{"key":"3400_CR57","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.snb.2013.12.005","volume":"193","author":"M Preis","year":"2014","unstructured":"Preis M, Eckert C, H\u00e4usler O, Breitkreutz J. A comparative study on solubilizing and taste-masking capacities of hydroxypropyl-\u03b2-cyclodextrin and maltodextrins with high amylose content. Sens Actuators B Chem. 2014;193:442\u201350.","journal-title":"Sens Actuators B Chem"},{"issue":"2","key":"3400_CR58","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/jpp\/rgac090","volume":"75","author":"K Commey","year":"2023","unstructured":"Commey K, Nakatake A, Enaka A, Nishi K, Tsukigawa K, Yamaguchi K, et al. Study of the inclusion complexes formed between 4-phenylbutyrate and \u03b1-, \u03b2- and \u03b3-cyclodextrin in solution and evaluation on their taste-masking properties. J Pharm Pharmacol. 2023;75(2):236\u201344.","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20132","key":"3400_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijpharm.2011.04.022","volume":"413","author":"Y Miyamoto","year":"2011","unstructured":"Miyamoto Y, Nakahara M, Motoyama K, Ishiguro T, Oda Y, Yamanoi T, et al. Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins. Int J Pharm. 2011;413(1\u20132):63\u201372.","journal-title":"Int J Pharm"},{"issue":"14","key":"3400_CR60","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2174\/1389450121666200615150039","volume":"21","author":"M Lachowicz","year":"2020","unstructured":"Lachowicz M, Sta\u0144czak A, Ko\u0142odziejczyk M. Characteristic of cyclodextrins: their role and use in the pharmaceutical technology. Curr Drug Targets. 2020;21(14):1495\u2013510.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"3400_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124809","volume":"666","author":"HM Johnsen","year":"2024","unstructured":"Johnsen HM, Filtvedt W, Klaveness J, Hiorth M. Nano-strategies for advancing oral drug delivery: porous silicon particles and cyclodextrin encapsulation for enhanced dissolution of poorly soluble drugs. Int J Pharm. 2024;666(5):124809.","journal-title":"Int J Pharm"},{"issue":"22","key":"3400_CR62","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1039\/b717509d","volume":"10","author":"W Cai","year":"2008","unstructured":"Cai W, Sun T, Shao X, Chipot C. Can the anomalous aqueous solubility of \u03b2-cyclodextrin be explained by its hydration free energy alone? Phys Chem Chem Phys. 2008;10(22):3236\u201343.","journal-title":"Phys Chem Chem Phys"},{"issue":"5","key":"3400_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051204","volume":"23","author":"M Kfoury","year":"2018","unstructured":"Kfoury M, Landy D, Fourmentin S. Characterization of cyclodextrin\/volatile inclusion complexes: a review. Molecules. 2018;23(5):1204.","journal-title":"Molecules"},{"issue":"24","key":"3400_CR64","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3390\/molecules26247538","volume":"26","author":"N Dudhipala","year":"2021","unstructured":"Dudhipala N, Ettireddy S, Youssef AA, Puchchakayala G. Cyclodextrin complexed lipid nanoparticles of irbesartan for oral applications: design, development, and in vitro characterization. Molecules. 2021;26(24):7538.","journal-title":"Molecules"},{"issue":"5","key":"3400_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2024.134602","volume":"698","author":"AV Sharapova","year":"2024","unstructured":"Sharapova AV, Ol\u2019khovich MV, Blokhina SV. Integrative approach for improved dofetilide solubility using \u03b2-cyclodextrin and two its substituted derivatives: solutions and solid dispersions. Colloids Surf A Physicochem Eng Asp. 2024;698(5):134602.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"665","key":"3400_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124718","volume":"15","author":"F De Gaetano","year":"2024","unstructured":"De Gaetano F, Mannino D, Celesti C, Bulzom\u00ed M, Iraci N, Giofr\u00e8 SV, et al. Randomly methylated \u03b2-cyclodextrin improves water\u2013solubility, cellular protection and mucosa permeability of idebenone. Int J Pharm. 2024;15(665):124718.","journal-title":"Int J Pharm"},{"issue":"11","key":"3400_CR67","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1002\/jps.20878","volume":"96","author":"CM Buchanan","year":"2007","unstructured":"Buchanan CM, Buchanan NL, Edgar KJ, Klein S, Little JL, Ramsey MG, et al. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole\u2010cyclodextrin formulations. J Pharm Sci. 2007;96(11):3100\u201316.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3400_CR68","first-page":"8","volume":"2","author":"M Shah","year":"2015","unstructured":"Shah M, Shah V, Ghosh A, Zhang Z, Minko T. Molecular inclusion complexes of \u03b2-cyclodextrin derivatives enhance aqueous solubility and cellular internalization of paclitaxel: preformulation and in vitro assessments. Journal of pharmaceutics & pharmacology. 2015;2(2):8.","journal-title":"Journal of pharmaceutics & pharmacology"},{"issue":"7","key":"3400_CR69","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1080\/00498254.2022.2136044","volume":"52","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Lv Y, Hu M, Guo F, Zhang C. Curcumin-loaded hydroxypropyl-\u03b2-cyclodextrin inclusion complex with enhanced dissolution and oral bioavailability for epilepsy treatment. Xenobiotica. 2022;52(7):718\u201328.","journal-title":"Xenobiotica"},{"issue":"12","key":"3400_CR70","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1080\/03639045.2018.1505904","volume":"44","author":"N Li","year":"2018","unstructured":"Li N, Wang N, Wu T, Qiu C, Wang X, Jiang S, et al. Preparation of curcumin-hydroxypropyl-\u03b2-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Drug Dev Ind Pharm. 2018;44(12):1966\u201374.","journal-title":"Drug Dev Ind Pharm"},{"key":"3400_CR71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.molliq.2018.04.007","volume":"261","author":"SK Das","year":"2018","unstructured":"Das SK, Kahali N, Bose A, Khanam J. Physicochemical characterization and in vitro dissolution performance of ibuprofen-Captisol\u00ae (sulfobutylether sodium salt of \u03b2-CD) inclusion complexes. J Mol Liq. 2018;261:239\u201349.","journal-title":"J Mol Liq"},{"issue":"3","key":"3400_CR72","doi-asserted-by":"publisher","DOI":"10.1208\/pt070379","volume":"7","author":"KP Chowdary","year":"2006","unstructured":"Chowdary KP, Srinivas SV. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl \u03b2-cyclodextrin. AAPS PharmSciTech. 2006;7(3):79.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3400_CR73","first-page":"380","volume":"4","author":"MA Marzouk","year":"2010","unstructured":"Marzouk MA, Kassem AA, Samy AM, Amer RI. Comparative evaluation of ketoconazole-\u03b2-cyclodextrin systems prepared by coprecipitation and kneading. Drug Discov Ther. 2010;4(5):380\u20137.","journal-title":"Drug Discov Ther"},{"issue":"662","key":"3400_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124485","volume":"5","author":"P Singh","year":"2024","unstructured":"Singh P, Mahar R. Cyclodextrin in drug delivery: Exploring scaffolds, properties, and cutting-edge applications. Int J Pharm. 2024;5(662):124485.","journal-title":"Int J Pharm"},{"issue":"378","key":"3400_CR75","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2017.12.003","volume":"1","author":"H Cai","year":"2019","unstructured":"Cai H, Huang YL, Li D. Biological metal\u2013organic frameworks: Structures, host\u2013guest chemistry and bio-applications. Coord Chem Rev. 2019;1(378):207\u201321.","journal-title":"Coord Chem Rev"},{"issue":"2","key":"3400_CR76","first-page":"83","volume":"61","author":"T Loftsson","year":"2006","unstructured":"Loftsson T, Konradsdottir F, M\u00e1sson M. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2006;61(2):83\u20139.","journal-title":"Die Pharmazie-An International Journal of Pharmaceutical Sciences"},{"key":"3400_CR77","doi-asserted-by":"crossref","unstructured":"Bilensoy E, editor. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: current and future industrial applications. Hoboken, NJ: John Wiley & Sons; 2011.","DOI":"10.1002\/9780470926819"},{"issue":"14","key":"3400_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceja.2023.100487","volume":"15","author":"YD Yue","year":"2023","unstructured":"Yue YD, Cui YY, Yang CX. Construction of cyclodextrin microporous organic network based drug delivery platform for controllable release and targeting delivery of doxorubicin. Chemical Engineering Journal Advances. 2023;15(14):100487.","journal-title":"Chemical Engineering Journal Advances"},{"issue":"181","key":"3400_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2022.111645","volume":"5","author":"A Degirmenci","year":"2022","unstructured":"Degirmenci A, Ipek H, Sanyal R, Sanyal A. Cyclodextrin-containing redox-responsive nanogels: Fabrication of a modular targeted drug delivery system. Eur Polymer J. 2022;5(181):111645.","journal-title":"Eur Polymer J"},{"issue":"1","key":"3400_CR80","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2013.10.005","volume":"458","author":"Y Ye","year":"2013","unstructured":"Ye Y, Sun Y, Zhao H, Lan M, Gao F, Song C, et al. A novel lactoferrin-modified \u03b2-cyclodextrin nanocarrier for brain-targeting drug delivery. Int J Pharm. 2013;458(1):110\u20137.","journal-title":"Int J Pharm"},{"issue":"22","key":"3400_CR81","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3390\/molecules29225319","volume":"29","author":"AM Musuc","year":"2024","unstructured":"Musuc AM. Cyclodextrins: Advances in chemistry, toxicology, and multifaceted applications. Molecules. 2024;29(22):5319.","journal-title":"Molecules"},{"issue":"12","key":"3400_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120801","volume":"9","author":"SS Braga","year":"2019","unstructured":"Braga SS. Cyclodextrins: emerging medicines of the new millennium. Biomolecules. 2019;9(12):801.","journal-title":"Biomolecules"},{"issue":"2","key":"3400_CR83","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.xphs.2020.10.026","volume":"110","author":"T Loftsson","year":"2021","unstructured":"Loftsson T. Cyclodextrins in parenteral formulations. J Pharm Sci. 2021;110(2):654\u201364.","journal-title":"J Pharm Sci"},{"key":"3400_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032974","author":"B Almeida","year":"2023","unstructured":"Almeida B, Domingues C, Mascarenhas-Melo F, Silva I, Jarak I, Veiga F, et al. The role of cyclodextrins in COVID-19 therapy-a literature review. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032974.","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"3400_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-5173(01)00761-X","volume":"225","author":"T Loftsson","year":"2001","unstructured":"Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm. 2001;225(1\u20132):15\u201330.","journal-title":"Int J Pharm"},{"issue":"221","key":"3400_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.113012","volume":"1","author":"L Ferreira","year":"2023","unstructured":"Ferreira L, Mascarenhas-Melo F, Raba\u00e7a S, Mathur A, Sharma A, Giram PS, et al. Cyclodextrin-based dermatological formulations: Dermopharmaceutical and cosmetic applications. Colloids Surf, B. 2023;1(221):113012.","journal-title":"Colloids Surf, B"},{"issue":"6","key":"3400_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics12060244","volume":"12","author":"I Conesa","year":"2025","unstructured":"Conesa I, Vidal-S\u00e1nchez FJ, Navarro-Orcajada S, Abril-S\u00e1nchez C, Matencio A, L\u00f3pez-Nicol\u00e1s JM. Cyclodextrin applications in the cosmetic industry: a review. Cosmetics. 2025;12(6):244.","journal-title":"Cosmetics"},{"key":"3400_CR88","unstructured":"World Health Organization. The International Pharmacopoeia. 4th ed. Geneva: World Health Organization; 2006."},{"key":"3400_CR89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/9780470926819.ch14","volume":"9","author":"A Singh","year":"2011","unstructured":"Singh A, Kaler A, Singh V, Patil R, Banerjee UC. Cyclodextrins and Biotechnological Applications. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications. 2011;9:275\u201385.","journal-title":"Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications"},{"key":"3400_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1201\/9781003492757-13","volume-title":"Cyclodextrins for UV Rays Filtration","author":"S Saha","year":"2025","unstructured":"Saha S, Dutta T, Kundu SK, Kabir E, Khan AA. Impact of Cyclodextrins on the Ultraviolet\/Sun Protection Factors (UVPF\/SPF) of UVR Absorbers. In: Cyclodextrins for UV Rays Filtration. CRC Press; 2025. p. 195\u2013212."},{"key":"3400_CR91","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-981-16-8146-2_15","volume":"11","author":"S Amiri","year":"2022","unstructured":"Amiri S, Amiri S. CDs: A potential candidate for improving water solubility and stability of hydrophobic guest molecules. Micro-and Nano-containers for Smart Applications. 2022;11:327\u201357.","journal-title":"Micro-and Nano-containers for Smart Applications"},{"issue":"54","key":"3400_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101238","volume":"1","author":"RN Shamma","year":"2019","unstructured":"Shamma RN, Ad-din IS, Abdeltawab NF. Dapsone-gel as a novel platform for acne treatment: In vitro evaluation and In vivo performance and histopathological studies in acne infected mice. Journal of Drug Delivery Science and Technology. 2019;1(54):101238.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3400_CR93","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.phymed.2018.11.012","volume":"57","author":"S-S Hu","year":"2019","unstructured":"Hu S-S, Lai Y-C, Lin C-L, Tzeng W-S, Yen F-L. Inclusion complex of saikosaponin-d with hydroxypropyl-\u03b2-cyclodextrin: improved physicochemical properties and anti-skin cancer activity. Phytomedicine. 2019;57:174\u201382.","journal-title":"Phytomedicine"},{"issue":"12","key":"3400_CR94","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/pharmaceutics13122131","volume":"13","author":"DA Real","year":"2021","unstructured":"Real DA, Bolanos K, Priotti J, Yutronic N, Kogan MJ, Sierpe R, et al. Cyclodextrin-modified nanomaterials for drug delivery: Classification and advances in controlled release and bioavailability. Pharmaceutics. 2021;13(12):2131.","journal-title":"Pharmaceutics"},{"key":"3400_CR95","unstructured":"Raba\u00e7a MSSB. Dermatological and cosmetic applications of cyclodextrins [Master\u2019s thesis]. Coimbra (Portugal): Universidade de Coimbra; 2019."},{"issue":"10","key":"3400_CR96","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1111\/jocd.16415","volume":"23","author":"J Zhong","year":"2024","unstructured":"Zhong J, Zhao N, Song Q, Du Z, Shu P. Topical retinoids: novel derivatives, nano lipid\u2010based carriers, and combinations to improve chemical instability and skin irritation. J Cosmet Dermatol. 2024;23(10):3102\u201315.","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"3400_CR97","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.injury.2017.08.046","volume":"48","author":"JCF Besson","year":"2017","unstructured":"Besson JCF, Hernandes L, de Campos JM, Morikawa KA, Bersani-Amado CA, Matioli G. Insulin complexed with cyclodextrins stimulates epithelialization and neovascularization of skin wound healing in rats. Injury. 2017;48(11):2417\u201325.","journal-title":"Injury"},{"key":"3400_CR98","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijbiomac.2017.01.144","volume":"98","author":"N Wathoni","year":"2017","unstructured":"Wathoni N, Motoyama K, Higashi T, Okajima M, Kaneko T, Arima H. Enhancement of curcumin wound healing ability by complexation with 2-hydroxypropyl-\u03b3-cyclodextrin in sacran hydrogel film. Int J Biol Macromol. 2017;98:268\u201376.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3400_CR99","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00266-012-9903-4","volume":"36","author":"T Miura","year":"2012","unstructured":"Miura T, Takada A, Ooe M. Tretinoin cyclodextrin complex (RA\/CyD) causes less irritation with an equal antiwrinkle effect compared with conventional tretinoin: clinical and histologic studies of photoaged skin. Aesthet Plast Surg. 2012;36(4):971\u201381.","journal-title":"Aesthet Plast Surg"},{"issue":"1","key":"3400_CR100","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1039\/C7NR04480A","volume":"10","author":"M Giulbudagian","year":"2018","unstructured":"Giulbudagian M, H\u00f6nzke S, Bergueiro J, I\u015f\u0131k D, Schumacher F, Saeidpour S, et al. Enhanced topical delivery of dexamethasone by \u03b2-cyclodextrin decorated thermoresponsive nanogels. Nanoscale. 2018;10(1):469\u201379.","journal-title":"Nanoscale"},{"key":"3400_CR101","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2147\/IJN.S246783","volume":"15","author":"L Wu","year":"2020","unstructured":"Wu L, Liu G, Wang W, Liu R, Liao L, Cheng N, et al. Cyclodextrin-modified CeO2 nanoparticles as a multifunctional nanozyme for combinational therapy of psoriasis. Int J Nanomed. 2020;15:2515\u201327.","journal-title":"Int J Nanomed"},{"issue":"3","key":"3400_CR102","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10973-020-09763-z","volume":"141","author":"D C\u00eercioban","year":"2020","unstructured":"C\u00eercioban D, Lede\u0163i A, Vlase G, Lede\u0163i I, Vlase T, V\u0103ru\u021b R, et al. Preparation, physicochemical characterization and biological activity evaluation of some inclusion complexes containing artesunate. J Therm Anal Calorim. 2020;141(3):1041\u201351.","journal-title":"J Therm Anal Calorim"},{"key":"3400_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10856-016-5804-4","volume":"27","author":"K Reddersen","year":"2016","unstructured":"Reddersen K, Finger S, Zieger M, Wiegand C, Buschmann H-J, Elsner P, et al. Cytocompatibility testing of cyclodextrin-functionalized antimicrobial textiles\u2014a comprehensive approach. J Mater Sci Mater Med. 2016;27:1\u201312.","journal-title":"J Mater Sci Mater Med"},{"issue":"1","key":"3400_CR104","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/08982104.2016.1254241","volume":"28","author":"N Akhtar","year":"2018","unstructured":"Akhtar N, Verma A, Pathak K. Investigating the penetrating potential of nanocomposite \u03b2-cycloethosomes: development using central composite design, in vitro and ex vivo characterization. J Liposome Res. 2018;28(1):35\u201348.","journal-title":"J Liposome Res"},{"issue":"31","key":"3400_CR105","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.2174\/0929867325666180313110917","volume":"25","author":"AC Raminelli","year":"2018","unstructured":"Raminelli AC, Romero V, Semreen MH, Leonardi GR. Nanotechnological advances for cutaneous release of tretinoin: an approach to minimize side effects and improve therapeutic efficacy. Curr Med Chem. 2018;25(31):3703\u201318.","journal-title":"Curr Med Chem"},{"key":"3400_CR106","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10847-013-0293-2","volume":"78","author":"U Badilli","year":"2014","unstructured":"Badilli U, Amasya G, \u015een T, Tarimci N. Topical emulgel formulation containing inclusion complex of calcipotriol with cyclodextrin. J Incl Phenom Macrocycl Chem. 2014;78:249\u201355.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"3400_CR107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1142\/9789813229662_0006","volume-title":"Cyclodextrins","author":"T Feng","year":"2018","unstructured":"Feng T, Zhuang H, Yang N. Applications in Cosmetics. In: Cyclodextrins. Singapore: World Scientific; 2018. p. 143\u2013207."},{"issue":"3","key":"3400_CR108","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3109\/10717544.2014.938839","volume":"23","author":"N Sharma","year":"2016","unstructured":"Sharma N, Baldi A. Exploring versatile applications of cyclodextrins: an overview. Drug Deliv. 2016;23(3):729\u201347.","journal-title":"Drug Deliv"},{"issue":"1","key":"3400_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0168-3659(02)00465-0","volume":"88","author":"CM Fernandes","year":"2003","unstructured":"Fernandes CM, Ramos P, Falcao AC, Veiga FJB. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits. J Control Release. 2003;88(1):127\u201334.","journal-title":"J Control Release"},{"key":"3400_CR110","doi-asserted-by":"crossref","unstructured":"T\u00f8nnesen HH, M\u00e1sson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. International journal of pharmaceutics. 2002;244(1\u20132):127\u201335.","DOI":"10.1016\/S0378-5173(02)00323-X"},{"issue":"1228","key":"3400_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129774","volume":"15","author":"P Arya","year":"2021","unstructured":"Arya P, Raghav N. In-vitro studies of Curcumin-\u03b2-cyclodextrin inclusion complex as sustained release system. J Mol Struct. 2021;15(1228):129774.","journal-title":"J Mol Struct"},{"key":"3400_CR112","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00394-016-1376-9","volume":"57","author":"M Purpura","year":"2018","unstructured":"Purpura M, Lowery RP, Wilson JM, Mannan H, M\u00fcnch G, Razmovski-Naumovski V. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nutr. 2018;57:929\u201338.","journal-title":"Eur J Nutr"},{"key":"3400_CR113","unstructured":"Uekama K, Hirayama F, Irie T. High Performance Biomaterials, A Comprehensive Guide to Medical and Pharmaceutical Applications. by Szycher M, Technomic Publishing Co Inc, Lancaster. 1991:789\u2013806."},{"key":"3400_CR114","unstructured":"Mesens J, Putteman P, Verheyen P. New Trends in Cyclodextrins and Derivatives. by D Duch\u00eane, Editions de Sant\u00e9, Paris. 1991:369\u2013407."},{"key":"3400_CR115","doi-asserted-by":"crossref","unstructured":"Fr\u00f6mming KH, Szejtli J. Cyclodextrins in pharmacy. Dordrecht: Springer Science & Business Media; 1993.","DOI":"10.1007\/978-94-015-8277-3"},{"issue":"8","key":"3400_CR116","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jps.2600840805","volume":"84","author":"RA Rajewski","year":"1995","unstructured":"Rajewski RA, Traiger G, Bresnahan J, Jaberaboansar P, Stella VJ, Thompson DO. Preliminary safety evaluation of parenterally administered sulfoalkyl ether \u03b2\u2010cyclodextrin derivatives. J Pharm Sci. 1995;84(8):927\u201332.","journal-title":"J Pharm Sci"},{"issue":"3","key":"3400_CR117","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2125.2011.04000.x","volume":"72","author":"HJ Kleijn","year":"2011","unstructured":"Kleijn HJ, Zollinger DP, van den Heuvel MW, Kerbusch T. Population pharmacokinetic\u2013pharmacodynamic analysis for sugammadex\u2010mediated reversal of rocuronium\u2010induced neuromuscular blockade. Br J Clin Pharmacol. 2011;72(3):415\u201333.","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"3400_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","volume":"329","author":"T Loftsson","year":"2007","unstructured":"Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1\u20132):1\u201311.","journal-title":"Int J Pharm"},{"issue":"50","key":"3400_CR119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/bs.podrm.2024.09.003","volume":"1","author":"A Khurshid","year":"2025","unstructured":"Khurshid A, Anwar Z, Khurshid A, Ahmed S, Sheraz MA, Ahmad I. Cyclodextrins and their applications in pharmaceutical and related fields. Profiles of Drug Substances, Excipients and Related Methodology. 2025;1(50):183\u2013227.","journal-title":"Profiles of Drug Substances, Excipients and Related Methodology"},{"issue":"6","key":"3400_CR120","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11095-023-03517-w","volume":"40","author":"SR Munnangi","year":"2023","unstructured":"Munnangi SR, Youssef AAA, Narala N, Lakkala P, Narala S, Vemula SK, et al. Drug complexes: perspective from academic research and pharmaceutical market. Pharm Res. 2023;40(6):1519\u201340.","journal-title":"Pharm Res"},{"issue":"10","key":"3400_CR121","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","volume":"43","author":"S Gould","year":"2005","unstructured":"Gould S, Scott RC. 2-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): a toxicology review. Food Chem Toxicol. 2005;43(10):1451\u20139.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"3400_CR122","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0378-5173(88)90081-6","volume":"46","author":"A Yoshida","year":"1988","unstructured":"Yoshida A, Arima H, Uekama K, Pitha J. Pharmaceutical evaluation of hydroxyalkyl ethers of \u03b2-cyclodextrins. Int J Pharm. 1988;46(3):217\u201322.","journal-title":"Int J Pharm"},{"issue":"1","key":"3400_CR123","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","volume":"36","author":"T Loftssona","year":"1999","unstructured":"Loftssona T, J\u00e4rvinen T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev. 1999;36(1):59\u201379.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3400_CR124","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1021\/js9704341","volume":"87","author":"L Szente","year":"1998","unstructured":"Szente L, Szejtli J, Kis GL. Spontaneous opalescence of aqueous \u03b3-Cyclodextrin solutions: complex formation or self-aggregation? J Pharm Sci. 1998;87(6):778\u201381.","journal-title":"J Pharm Sci"},{"key":"3400_CR125","unstructured":"Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection [Internet]. 2023\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05926245."},{"key":"3400_CR126","unstructured":"Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease [Internet]. 2012\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01747135."},{"key":"3400_CR127","unstructured":"A Single Center, Randomized, Double-blind, Placebo Controlled, Two-way Crossover Study to Determine the Fat Losses in Stool Associated With Alpha-CD Use as Compared to Placebo Using a Radiotracer [Internet]. 2016\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03002168."},{"key":"3400_CR128","unstructured":"Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Spectroscopic Evaluation of Molecular Inclusion and Use of the Complex in Gel for Healing of Pressure Ulcers [Internet]. 2015\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02418676."},{"key":"3400_CR129","unstructured":"A Randomized, Double-Blind, 2-Period Crossover Trial to Determine the Relative Bioavailability of CE-Iohexol (Iohexol\/Sulfobutylether-\u03b2-Cyclodextrin ( Captisol\u00ae)) Injection and Omnipaque\u2122 (Iohexol) Injection in Healthy Adult Volunteers [Internet]. 2019\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03869983."},{"key":"3400_CR130","unstructured":"A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma [Internet]. 2000\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00005668."},{"key":"3400_CR131","unstructured":"Preemptive Use of Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching: Randomized, Triple-blind, Controlled Clinical Trial [Internet]. 2017\u00a0[cited 2026 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03153657."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03400-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:02:35Z","timestamp":1780506155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03400-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":131,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3400"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03400-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflicts of interest, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"194"}}